Cronos Group Inc. ($CRON) Stock Forecast: Down 5.6% Today

What is Cronos Group Inc.?

CRON is the ticker symbol for Cronos Group, a cannabis company listed on the NASDAQ. The company reported a strong first quarter in 2026 with significant revenue growth and profit increases.

Why is Cronos Group Inc. going down?

CRON stock is down 5.6% on May 11, 2026 14:00

• Despite the strong financial performance and revenue growth reported by Cronos Group in Q1 2026, the market reacted bearishly, possibly due to profit-taking after a period of positive developments.
• The announcement of a new $50 million share repurchase program and the extension of the CanAdelaar B.V. acquisition deadline may have raised concerns among investors about the company's capital allocation strategy.
• The market movement could also be influenced by profit margins and bottom-line profitability concerns highlighted by analysts, despite the company's strong revenue figures.
• Overall, the bearish movement in CRON's stock price today may be a result of a combination of factors, including profit-taking, investor sentiment towards share buybacks, and lingering concerns about profitability metrics.

CRON Price Chart

CRON Technical Analysis

CRON News

Cronos Group Announces New Share Buyback After Strong Quarter

Cronos Group (TSE:CRON) has announced a new $50 million share repurchase program following a strong first quarter in 2026, which saw a 40% year-over-year revenue increase to $45.2 million and record gross profit. The company also extended the deadline for its CanAdelaar B.V. acquisition to September 2026 to secure necessary Dutch regulatory approvals. Spark, TipRanks’ AI Analyst, rates CRON as Neutral, noting strong financial resilience but weak bottom-line profitability.

https://www.tipranks.com/news/company-announcements/cronos-group-announces-new-share-buyback-after-strong-quarter

Earnings Flash (CRON) Cronos Group Inc. Reports Q1 Revenue $45.2M, vs. FactSet Est of $42.2M

Cronos Group Inc. has reported its first-quarter revenue of $45.2 million, surpassing the FactSet estimate of $42.2 million. The cannabis company's Q1 net revenue increased by 40% year-over-year. This financial update indicates stronger than anticipated performance for the quarter.

https://www.marketscreener.com/news/earnings-flash-cron-cronos-group-inc-reports-q1-revenue-45-2m-vs-factset-est-of-42-2m-ce7f5bd8d088f321

Cronos Group (NASDAQ: CRON) posts higher Q1 2026 profit and expands buybacks

Cronos Group reported a significantly stronger Q1 2026, with net revenue rising to $45.2 million and net income attributable to Cronos Group increasing to $13.75 million, up from $6.12 million in the prior year. Adjusted EBITDA more than doubled to $5.08 million, driven by higher cannabis flower and extracts sales in Canada and Israel. The company also announced a new $50 million share repurchase program to succeed the existing one and holds $821.86 million in cash with no debt, indicating strong liquidity and a focus on capital returns.

https://www.stocktitan.net/sec-filings/CRON/10-q-cronos-group-inc-quarterly-earnings-report-dc87ab704d2d.html

Cronos: Q1 Earnings Snapshot

Cronos Group Inc. (CRON) reported first-quarter earnings of $13.8 million, resulting in a net income of 4 cents per share. After adjusting for non-recurring gains, the cannabis company's earnings were 1 cent per share, with total revenue reaching $45.2 million for the period.

https://www.king5.com/article/syndication/associatedpress/cronos-q1-earnings-snapshot/616-1e0bf8b3-99b4-4704-8a35-aba79b3e73f3

Cronos Group (NASDAQ: CRON) grows Q1 2026 revenue 40% and OKs $50M buyback

Cronos Group Inc. reported strong first-quarter 2026 results, with net revenue increasing 40% year-over-year to $45.2 million and net income more than doubling to $15.7 million. The company also authorized a new share repurchase program of up to $50 million and extended the closing date for its acquisition of Dutch producer CanAdelaar B.V. to September 9, 2026, to allow for regulatory clearances.

https://www.stocktitan.net/sec-filings/CRON/8-k-cronos-group-inc-reports-material-event-0f94395b30e3.html

Trending Today

Marathon Digital Holdings Inc. ($MARA) Stock Forecast: Up 6.3% Today

Digital Ocean Holdings ($DOCN) Stock Forecast: Up 5.4% Today

ARM Holdings plc ($ARM) Stock Forecast: Up 6.0% Today

Intellia Therapeutics, Inc. ($NTLA) Stock Forecast: Down 9.8% Today

Aptiv PLC ($APTV) Stock Forecast: Up 6.2% Today

TKO Group Holdings Inc ($TKO) Stock Forecast: Up 6.9% Today

Ford Motor Company ($F) Stock Forecast: Up 5.5% Today

Lyft Inc. ($LYFT) Stock Forecast: Down 5.2% Today

Bumble Inc. ($BMBL) Stock Forecast: Down 5.3% Today

Akamai Technologies Inc. ($AKAM) Stock Forecast: Down 5.2% Today

Cronos Group Inc. Price History

29.00.2026 - CRON Stock was down 7.0%

• Analysts at Canaccord Genuity Group issued a "buy" rating with a target price of C$4.25, indicating a possible upside. The general analyst consensus, however, continues to suggest a "Hold," with the average price target at $2.30.
• Although the company boasts a solid financial position with no debts and substantial cash reserves amounting to $824 million, concerns over a negative EPS forecast for the current fiscal year might have influenced the recent market decline.
• The company's strong operational performance and revenue growth in Q3 2025, largely propelled by the success of the Spinach brand and expansion initiatives, were somewhat overshadowed by uncertainties surrounding future profitability.
• The discussion of alternative AI stocks offering greater potential for market growth could have diverted investor focus from Cronos Group, contributing to its recent stock performance downturn.

19.11.2025 - CRON Stock was down 6.8%

• The bearish movement in CRON today could be attributed to profit-taking by investors after a series of significant stock price surges in response to the company's European expansion efforts.
• Despite the positive news of Cronos Group's strategic acquisition of CanAdelaar and its expansion into Europe, investors may be reevaluating the stock's valuation, which has been considered overvalued by some analysts.
• The high valuation and potential risks associated with delays or policy reversals in the cannabis sector may have contributed to the bearish sentiment towards CRON today.
• While the company's moves to capitalize on the evolving cannabis markets are promising, investors may be exercising caution amidst concerns about sustainability and profitability in the long term.

15.11.2025 - CRON Stock was down 5.0%

• Despite recent positive developments in Cronos Group's expansion into Europe and the surge in its stock price, today's bearish movement could be attributed to profit-taking by investors after a period of strong gains.
• Concerns about overvaluation and potential risks such as policy reversals or revenue growth delays might have contributed to the downward pressure on CRON's stock.
• Investors may be reevaluating their positions in CRON, considering the mixed financial metrics and the company's premium valuation compared to industry peers.
• While Cronos Group's strategic acquisitions and market expansions have generated positive feedback, market participants are likely being cautious amidst uncertainties in the cannabis sector and broader market conditions.

22.03.2026 - CRON Stock was up 17.2%

• After lagging behind the market in previous sessions, CRON displayed a notable bullish trend today.
• The scheduled 2026 first-quarter earnings conference call on May 11th may have instilled optimism and confidence among investors regarding the company's prospects.
• Positive market outlook towards the cannabis sector likely influenced the upward movement of CRON's stock.
• Investors seem keen on the upcoming earnings call for potential positive financial results and strategic updates from senior leadership, driving an increase in buying activity.

22.11.2025 - CRON Stock was down 5.1%

• The stock fell on Wednesday, underperforming the overall market, which could be attributed to profit-taking or market correction.
• Despite being considered a safer bet in the cannabis industry due to its strong financial position and disciplined management, the high valuation and limited direct benefits from potential US cannabis rescheduling might have dampened investor enthusiasm.
• The company's improved gross margins and profitability could be overshadowed by the broader market sentiment or sector-specific challenges, leading to the bearish movement in the stock today.
• Investors may be reevaluating their positions in CRON amidst uncertainties surrounding cannabis regulations and market dynamics, contributing to the downward pressure on the stock price.

12.00.2026 - CRON Stock was up 2.6%

• Cronos' bullish movement was driven by its recent announcement of expanding into the Netherlands through the acquisition of Europe’s largest adult-use cannabis company. This strategic move is expected to unlock new revenue streams and enhance Cronos' position in the global cannabis market.
• Furthermore, positive trading plans and investment analysis on CRON:CA may have also influenced the stock's upward momentum. Analysts and AI-generated ratings suggesting buying at specific price levels and implementing stop-loss measures could have instilled confidence in investors.
• In conclusion, Cronos' strategic expansion initiatives, along with favorable trading recommendations and investment analysis, have instilled optimism among investors, triggering the significant bullish movement observed in the stock today.

23.03.2026 - CRON Stock was down 7.9%

• Despite positive earnings and revenue estimates, Cronos Group (CRON) experienced a bearish movement today.
• The stock fell, underperforming the market, which also saw declines in the NASDAQ Composite Index and Dow Jones Industrial Average.
• The gap up in pre-market trading and the subsequent intraday volatility may have led to profit-taking by investors, contributing to the bearish movement.
• The overall negative market sentiment and profit-taking behavior could have overshadowed the positive financial performance reported by the company, leading to the stock's decline.

23.03.2026 - CRON Stock was down 6.1%

• Despite a recent 28% increase in net revenue year-over-year in Q1, Cronos Group Inc. faced a 1.09% drop in its stock price today, performing below market expectations.
• The upcoming first-quarter earnings conference call on May 11, 2026, may be causing uncertainty or prompting profit-taking among investors, influencing the bearish movement.
• Prior to today's decline, the stock had enjoyed two consecutive days of gains, implying potential profit-taking or market adjustment following a recent positive trend.
• The overall negative market session, marked by declines in both the NASDAQ Composite Index and Dow Jones Industrial Average, likely played a role in the bearish movement observed in Cronos Group Inc.'s stock price.

03.01.2026 - CRON Stock was up 5.1%

• The bullish movement in CRON today can be attributed to the launch of its premium cannabis brand, Lord Jones®, in Israel. This strategic expansion into new markets with high-quality products showcases the company's commitment to growth and innovation.
• Additionally, the bullish thesis surrounding potential regulatory changes in the US, specifically the reclassification of marijuana as a Schedule III substance, has likely fueled investor optimism. This shift could lead to improved financial performance for CRON by reducing tax burdens and enhancing operational efficiency.
• Despite recent declines and cautious Wall Street analyst ratings, CRON's forward-thinking approach to product strategy and potential regulatory tailwinds seem to have resonated positively with investors, driving the stock's bullish momentum today.

25.02.2026 - CRON Stock was up 5.2%

• Cronos Group Inc. (CRON) has been experiencing consecutive days of stock price increases, outperforming the broader market.
• Positive news such as beating EPS and revenue expectations in recent earnings reports and legislative efforts to protect legal cannabis businesses in the U.S. have likely contributed to the bullish momentum.
• Insider trading activity, with an officer exercising restricted stock units and increasing their direct holdings, may also signal confidence in the company's future prospects.
• The overall positive sentiment towards the cannabis sector and specific company developments seem to be driving the bullish movement in CRON stock despite its unprofitable status and negative margins.

15.03.2026 - CRON Stock was up 5.1%

• Cronos Group's stock (CRON) surged by 1.18% to $2.58, marking a three-day uptrend.
• Analysts have revised Cronos Group's price target to CA$4.50, highlighting the company's strong Canadian brands, focus on efficient revenue growth, and quality cultivation practices as growth catalysts.
• The company's market sentiment has improved due to its entry into the Swiss market and the launch of new products under well-established brands like Spinach and Lord Jones.
• Despite ongoing profitability challenges, Cronos Group's strategic advancements and positive analyst outlook have driven its stock performance above market trends.

11.04.2026 - CRON Stock was down 5.6%

• Despite the strong financial performance and revenue growth reported by Cronos Group in Q1 2026, the market reacted bearishly, possibly due to profit-taking after a period of positive developments.
• The announcement of a new $50 million share repurchase program and the extension of the CanAdelaar B.V. acquisition deadline may have raised concerns among investors about the company's capital allocation strategy.
• The market movement could also be influenced by profit margins and bottom-line profitability concerns highlighted by analysts, despite the company's strong revenue figures.
• Overall, the bearish movement in CRON's stock price today may be a result of a combination of factors, including profit-taking, investor sentiment towards share buybacks, and lingering concerns about profitability metrics.